BioLytical’s new Zika detection system is based on of the company’s HIV test, which detects the antibodies that a disease produces. Photo: Nechaevkon/Shutterstock

Canadian biotech company applies for patents on Zika detection method

BioLytical Laboratories has previously developed processes for fast detection of HIV and Ebola viruses

Topic |   Business in Vancouver

TOP PICKS

BioLytical’s new Zika detection system is based on of the company’s HIV test, which detects the antibodies that a disease produces. Photo: Nechaevkon/Shutterstock
READ FULL ARTICLE